Report error Found 36 Enz. Inhib. hit(s) with all data for entry = 50031349
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of ROCK2More data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of ROCK2More data for this Ligand-Target Pair
TargetRho-associated protein kinase 1(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 1(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 1(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetSerine/threonine-protein kinase MRCK alpha(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 247nMAssay Description:Inhibition of MRCKalphaMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
TargetRho-associated protein kinase 2(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of ROCK2More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 10(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 5.46E+3nMAssay Description:Inhibition of JNK3More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 7.86E+3nMAssay Description:Inhibition of MRCKalphaMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase MRCK alpha(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 9.55E+3nMAssay Description:Inhibition of MRCKalphaMore data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 10(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.38E+4nMAssay Description:Inhibition of JNK3More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 10(Human)
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Translational Research Institute and Department of Molecular Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of JNK3More data for this Ligand-Target Pair


























